Tigermed Named a Leading Brand by Forbes in 2025
Tigermed has achieved significant recognition by being selected as one of the top 30 companies in Forbes China's prestigious "2025 Go-International Flagship Brands" list. This selection underscores Tigermed's influence in the global biopharmaceutical landscape and its commitment to advancing healthcare solutions.
Understanding the Go-International Ranking
Forbes China initiated the Go-International ranking in 2023 with the intention of highlighting companies that are making strides in international markets. The rankings have evolved, and the 2025 edition includes four distinct categories: Flagship Brands, Leading Brands, Investment Value Brands, and Leading Figures. The flagship category is reserved for well-established, large companies recognized for their global reach and investments in overseas operations.
Tigermed's Global Impact
The inclusion of Tigermed on this list is a testament to its significant contributions to the global biopharmaceutical innovation scene. As a leader in clinical development services, Tigermed operates over 180 offices across the globe with a workforce exceeding 10,000 employees. Their presence spans North America, Europe, Asia-Pacific, Africa, and Latin America, showcasing their commitment to enhancing healthcare through integrated solutions.
Growth and Expansion Plans
Tigermed is firmly focused on expanding its global footprint. The company has laid out ambitious plans to strengthen local operations while accelerating its digital transformation efforts. In an era marked by growing international demand for biopharmaceutical services, Tigermed is poised to enhance its partnerships within the industry, thereby promoting China's pharmaceutical innovations and improving the overall quality of healthcare solutions.
Commitment to Excellence in Healthcare
At the heart of Tigermed’s mission is a dedication to delivering quality and innovative research-driven healthcare solutions. The company prides itself on its ability to address unmet patient needs efficiently and effectively while saving lives. Tigermed collaborates with more than 3,600 customers globally, ensuring that every step of the drug development journey is met with professionalism and expertise.
About Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) stands as a prominent global provider of comprehensive research and development services tailored for the biopharmaceutical and medical device sectors. With a strong emphasis on quality and a diverse range of services, Tigermed supports its clients every step of the way—from preclinical development to clinical trials and eventual commercialization. The global network boasts over 180 locations and a robust workforce, making it a significant player in the healthcare industry.
Frequently Asked Questions
What is the significance of the Forbes China Go-International ranking?
The Forbes China Go-International ranking highlights companies that excel in their global expansion efforts, showcasing their contributions to international markets.
What services does Tigermed offer?
Tigermed offers integrated solutions across the biopharmaceutical sector, including preclinical development, clinical trial management, and commercialization support.
How many employees does Tigermed have?
Tigermed employs more than 10,000 individuals across its global network of over 180 offices.
What are Tigermed's future plans?
The company plans to further expand its global operations, enhance local engagement, and accelerate digital transformation in response to international demand.
Where can I find more information about Tigermed?
Additional information about Tigermed and its services can be found on their official website.
